Publication Name	World Journal of Respirology
Manuscript ID	7017
Country	Japan

Received	2013-11-03 19:36
Peer-Review Started	2013-11-14 19:38
First Decision by Editorial Office Director
Return for Revision	2014-01-16 22:50
Revised	2014-01-17 11:28
Publication Fee Transferred
Second Decision by Editor	2014-02-19 11:17
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-02-19 11:40
Articles in Press
Edit the Manuscript by Language Editor	2014-03-13 06:30
Typeset the Manuscript	2014-03-26 11:49
Publish the Manuscript Online	2014-03-27 18:34

ISSN	2218-6255 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Prospective Study
Article Title	Phase Ⅱ trial of carboplatin/docetaxel in patients with resected NSCLC
Manuscript Source	Invited Manuscript
All Author List	Hidetaka Uramoto, Ryoichi Nakanishi, Akihiko Uchiyama, Masaaki Inoue, Masakazu Sugaya, Teruo Iwata, Noriyuki Ebi, Takeshi Hanagiri and Fumihiro Tanaka
Funding Agency and Grant Number	Funding Agency Grant Number JPJS KAKENHI 25462202 A UOEH Research Grant for Promotion of Occupational Health Sanofi-Aventis, Inc. (to Uramoto H, Hanagiri T and Tanaka F)
Corresponding Author	Hidetaka Uramoto, MD, PhD, Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan. hidetaka@med.uoeh-u.ac.jp
Key Words	Non-small cell lung cancer; Adjuvant chemotherapy; Carboplatin; Docetaxel; Treatment compliance; Surgical resection
Core Tip	Adjuvant chemotherapy with a tri-weekly schedule of carboplatin and docetaxel was feasible in Japanese non-small cell lung cancer patients. In clinical practice, this regimen represents a potential treatment option that may be superior to other regimens. The main limitation associated with this study is the small number of patients enrolled. Therefore, it is important to employ a reference arm for any future randomized clinical trials evaluating this treatment regimen.
Publish Date	2014-03-27 18:34
Citation	Uramoto H, Nakanishi R, Uchiyama A, Inoue M, Sugaya M, Iwata T, Ebi N, Hanagiri T, Tanaka F. Phase Ⅱ trial of carboplatin/docetaxel in patients with resected NSCLC. World J Respirol 2014; 4(1): 1-7
URL	http://www.wjgnet.com/2218-6255/full/v4/i1/1.htm
DOI	http://dx.doi.org/10.5320/wjr.v4.i1.1

Full Article (PDF)	WJR-4-1.pdf
Full Article (Word)	WJR-4-1.doc
Manuscript File	7017-Review.docx
Answering Reviewers	7017-Answering reviewers.pdf
Copyright License Agreement	7017-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	Ethics_Committee_20131031155924.pdf
Non-Native Speakers of English Editing Certificate	7017-Language certificate.pdf
Peer-review Report	7017-Peer review(s).pdf
Scientific Editor Work List	7017-Scientific editor work list.doc